» Articles » PMID: 18404243

Utility Values Associated with Osteoporotic Fracture: a Systematic Review of the Literature

Overview
Specialty Pathology
Date 2008 Apr 12
PMID 18404243
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

We reviewed studies that have estimated the impact of osteoporotic fracture on quality-adjusted life years (QALY) and to determine reference values for countries that would like to carry out cost-utility analyses but that do not have their own values. The computerized medical literature databases Medline and EMBASE were searched from January 1990 to December 2006. The search was carried out in two steps. The first step was to identify studies that related to quality of life in osteoporosis. As part of the second step, only the studies that translated quality of life into a utility value (one single value for health status ranging 0-1) and calculated a utility loss over a period of at least 1 year were selected. From the 152 studies identified in the first analysis, only 16 were retained after the second step. Ten studies investigated utility values for hip fractures, 11 for vertebral fractures, five for distal forearm fractures, and four for other osteoporotic fractures and fracture interactions. Utility values differed substantially between studies, partly due to the valuation technique used, the severity of fractures, and the sample size. This review suggests that there is no meaningful average value across different studies, different samples, different countries, or different instruments. Although we tried to determine the best available values, these values do not preclude the need for country-specific studies. Finally, we also make recommendations regarding the design and methodology for such studies.

Citing Articles

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.

Nagendra L, Chandran M, Reginster J, Bhadada S, Bhattacharya S, Dutta D Osteoporos Int. 2024; 36(2):311-322.

PMID: 39730734 DOI: 10.1007/s00198-024-07328-6.


Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures.

Ruhling S, Schwarting J, Froelich M, Loffler M, Bodden J, Petzsche M Front Endocrinol (Lausanne). 2023; 14:1222041.

PMID: 37576975 PMC: 10422975. DOI: 10.3389/fendo.2023.1222041.


Economic evaluation of four treatment strategies for postmenopausal patients with osteoporosis and a recent fracture in mainland China: a cost-effectiveness analysis.

Tian L, Luo C, Li Y, Wang Q, Qu X, Yue C Arch Osteoporos. 2023; 18(1):100.

PMID: 37460858 DOI: 10.1007/s11657-023-01309-8.


Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk.

Luo C, Qin S, Wang Q, Li Y, Qu X, Yue C J Endocrinol Invest. 2022; 46(2):367-379.

PMID: 36044169 PMC: 9428883. DOI: 10.1007/s40618-022-01910-7.


Cost-Effectiveness Analysis of Fracture Liaison Services Compared with Standard of Care in the Secondary Prevention of Fragility Fractures in Spain.

Naranjo A, Prieto-Alhambra D, Sanchez-Martin J, Perez-Mitru A, Brosa M Clinicoecon Outcomes Res. 2022; 14:249-264.

PMID: 35492806 PMC: 9041144. DOI: 10.2147/CEOR.S350790.